Comparative Benchmarking
In the context of the broader market, FTH competes directly with industry leaders such as PROK and ALT. With a market capitalization of $673.08M, it holds a leading position in the sector. When comparing efficiency, FTH's gross margin of N/A stands against PROK's 100.00% and ALT's N/A. Such benchmarking helps identify whether Faeth Therapeutics, Inc is trading at a premium or discount relative to its financial performance.
